Summer Y Y Ha

6PUBLICATIONS
20CO-AUTHORS
Biologically active moleculesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Glycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 01, 2026
Antibody-oligonucleotide conjugates: an emerging modality for precision RNA therapeutics.

|Apr 14, 2026
Affinity-optimized TROP2 antibodies support potent antitumor activity in antibody-drug conjugates.

Aiko Yamaguchi, Junping Hong, Leike Li

|Mar 07, 2025
177Lu-Labeled Antibody-Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors.

Aiko Yamaguchi, Chisato M Yamazaki, Yasuaki Anami

|Jan 09, 2024
Exploring the next generation of antibody-drug conjugates.

Kyoji Tsuchikama, Yasuaki Anami, Summer Y Y Ha

|Jul 06, 2022
An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody-Drug Conjugates.

Summer Y Y Ha, Yasuaki Anami, Chisato M Yamazaki

|Nov 02, 2021
One-pot peptide cyclisation and surface modification of photosensitiser-loaded red blood cells for targeted photodynamic therapy.

Jacky C H Chu, Chihao Shao, Summer Y Y Ha

Pageof 1

Frequent Collaborators

5 joint publications

Kyoji Tsuchikama

4 joint publications

Zhiqiang An

3 joint publications

Yasuaki Anami

2 joint publications

Chisato M Yamazaki